The U.S. Supreme Court is set to begin a new term on October 7, which will include a case involving the vape industry that could further erode the authority of federal regulatory agencies. This follows other major rulings that have already limited regulatory power. The case will address important business-related questions and could impact the enforcement of health warnings by the U.S. Food and Drug Administration (FDA), according to a new study. Additionally, the term will feature cases involving tech giants Nvidia and Meta's Facebook, which could make it harder for private plaintiffs to win securities fraud lawsuits against companies in federal courts.